FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100885061> ?p ?o ?g. }

• W2100885061 endingPage "2951" @default.
• W2100885061 startingPage "2944" @default.
• W2100885061 abstract "Little is known about the utility of central nervous system (CNS) prophylaxis for diffuse large B-cell lymphoma (DLBCL) in the rituximab era. The objective of this study was to characterize patterns of CNS prophylaxis for patients who received combined rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy using the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes Database, a prospective cohort study that collects clinical and outcomes data for patients at 7 participating centers.Patients who were eligible for this analysis presented with newly diagnosed DLBCL between January 2001 and July 2008, had no evidence of baseline CNS disease, and had received R-CHOP within 180 days of diagnosis. The authors assessed incidence and covariates of prophylaxis, prophylaxis modality, and, using propensity score analysis, outcomes such as overall survival.Of 989 eligible patients, 117 received CNS prophylaxis (11.8%), most intrathecally (71.8%). Involvement of bone marrow, other high-risk site, >1 extranodal site, higher International Prognostic Index score, and higher stage were associated individually with the receipt of prophylaxis (all P < .0001). At a median follow-up of 2.5 years, there were 20 CNS recurrences (2% [95% confidence interval, 1.1%-2.9%]) among all patients, and overall survival was not affected by prophylaxis.Given the overall low rate of CNS recurrence and lack of prophylaxis-associated survival benefit, the current data called into question the practice of CNS prophylaxis in the rituximab era." @default.
• W2100885061 created "2016-06-24" @default.
• W2100885061 creator A5008456774 @default.
• W2100885061 creator A5015557803 @default.
• W2100885061 creator A5021262821 @default.
• W2100885061 creator A5025865972 @default.
• W2100885061 creator A5030855310 @default.
• W2100885061 creator A5038526399 @default.
• W2100885061 creator A5050222564 @default.
• W2100885061 creator A5052032114 @default.
• W2100885061 creator A5061964017 @default.
• W2100885061 creator A5069033960 @default.
• W2100885061 creator A5071631687 @default.
• W2100885061 creator A5085801543 @default.
• W2100885061 creator A5089206024 @default.
• W2100885061 creator A5091710463 @default.
• W2100885061 date "2011-10-17" @default.
• W2100885061 modified "2023-10-14" @default.
• W2100885061 title "Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era" @default.
• W2100885061 cites W173609426 @default.
• W2100885061 cites W1931431191 @default.
• W2100885061 cites W1966387704 @default.
• W2100885061 cites W1985382327 @default.
• W2100885061 cites W1995939575 @default.
• W2100885061 cites W2035387470 @default.
• W2100885061 cites W2057239580 @default.
• W2100885061 cites W2057369877 @default.
• W2100885061 cites W2058015212 @default.
• W2100885061 cites W2070662281 @default.
• W2100885061 cites W2074250932 @default.
• W2100885061 cites W2077554728 @default.
• W2100885061 cites W2089242301 @default.
• W2100885061 cites W2096047333 @default.
• W2100885061 cites W2100367991 @default.
• W2100885061 cites W2113971895 @default.
• W2100885061 cites W2131338392 @default.
• W2100885061 cites W2138938132 @default.
• W2100885061 cites W2143536992 @default.
• W2100885061 cites W2155495849 @default.
• W2100885061 cites W2162693374 @default.
• W2100885061 cites W2167425679 @default.
• W2100885061 cites W2472782432 @default.
• W2100885061 cites W2593145332 @default.
• W2100885061 cites W4239728164 @default.
• W2100885061 cites W866601693 @default.
• W2100885061 doi "https://doi.org/10.1002/cncr.26588" @default.
• W2100885061 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22006274" @default.
• W2100885061 hasPublicationYear "2011" @default.
• W2100885061 type Work @default.
• W2100885061 sameAs 2100885061 @default.
• W2100885061 citedByCount "75" @default.
• W2100885061 countsByYear W21008850612012 @default.
• W2100885061 countsByYear W21008850612013 @default.
• W2100885061 countsByYear W21008850612014 @default.
• W2100885061 countsByYear W21008850612015 @default.
• W2100885061 countsByYear W21008850612016 @default.
• W2100885061 countsByYear W21008850612017 @default.
• W2100885061 countsByYear W21008850612018 @default.
• W2100885061 countsByYear W21008850612019 @default.
• W2100885061 countsByYear W21008850612020 @default.
• W2100885061 countsByYear W21008850612021 @default.
• W2100885061 countsByYear W21008850612022 @default.
• W2100885061 countsByYear W21008850612023 @default.
• W2100885061 crossrefType "journal-article" @default.
• W2100885061 hasAuthorship W2100885061A5008456774 @default.
• W2100885061 hasAuthorship W2100885061A5015557803 @default.
• W2100885061 hasAuthorship W2100885061A5021262821 @default.
• W2100885061 hasAuthorship W2100885061A5025865972 @default.
• W2100885061 hasAuthorship W2100885061A5030855310 @default.
• W2100885061 hasAuthorship W2100885061A5038526399 @default.
• W2100885061 hasAuthorship W2100885061A5050222564 @default.
• W2100885061 hasAuthorship W2100885061A5052032114 @default.
• W2100885061 hasAuthorship W2100885061A5061964017 @default.
• W2100885061 hasAuthorship W2100885061A5069033960 @default.
• W2100885061 hasAuthorship W2100885061A5071631687 @default.
• W2100885061 hasAuthorship W2100885061A5085801543 @default.
• W2100885061 hasAuthorship W2100885061A5089206024 @default.
• W2100885061 hasAuthorship W2100885061A5091710463 @default.
• W2100885061 hasBestOaLocation W21008850611 @default.
• W2100885061 hasConcept C126322002 @default.
• W2100885061 hasConcept C141071460 @default.
• W2100885061 hasConcept C143998085 @default.
• W2100885061 hasConcept C2776694085 @default.
• W2100885061 hasConcept C2776755627 @default.
• W2100885061 hasConcept C2778476033 @default.
• W2100885061 hasConcept C2778559949 @default.
• W2100885061 hasConcept C2778720950 @default.
• W2100885061 hasConcept C2779338263 @default.
• W2100885061 hasConcept C2779429289 @default.
• W2100885061 hasConcept C2779725641 @default.
• W2100885061 hasConcept C2780653079 @default.
• W2100885061 hasConcept C71924100 @default.
• W2100885061 hasConceptScore W2100885061C126322002 @default.
• W2100885061 hasConceptScore W2100885061C141071460 @default.
• W2100885061 hasConceptScore W2100885061C143998085 @default.
• W2100885061 hasConceptScore W2100885061C2776694085 @default.
• W2100885061 hasConceptScore W2100885061C2776755627 @default.
• W2100885061 hasConceptScore W2100885061C2778476033 @default.

• next